AI Insight
Researchers at Niigata University have conducted the first comprehensive reassessment in nearly three decades of Alzheimer's disease risk associated with APOE-e4 homozygosity in the Japanese population. The study, published in Molecular Neurodegeneration, found that while individuals carrying two copies of the APOE-e4 gene variant remain at substantially elevated risk for developing Alzheimer's disease, this risk appears to be lower than the estimates that have been widely used since the 1990s. This represents an important update to our understanding of genetic risk factors for Alzheimer's disease in Asian populations.
Why it matters
The findings may lead to more accurate risk assessments and counseling for Japanese individuals undergoing genetic testing for Alzheimer's disease predisposition. This research also highlights the importance of population-specific genetic studies, as risk estimates developed in one ethnic group may not directly apply to others.
Understand the Science
Researchers at Niigata University have conducted the first comprehensive reappraisal in nearly 30 years of the risk of Alzheimer’s disease (AD) associated with APOE-e4 homozygosity (e4*4) in the Japanese population. Their findings, published in the journal Molecular Neurodegeneration, suggest that the risk, while still substantial, is lower than estimates that have been widely cited since the 1990s.
Source: Thirty years later: A reappraisal of Alzheimer's disease risk in Japanese APOE-e4 homozygotes